KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShare-based Compensation (IS)Share-based Compensation (IS)Shares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Nova (NVMI) Research & Development (2016 - 2025)

Nova filings provide 17 years of Research & Development readings, the most recent being $38.0 million for Q4 2025.

  • On a quarterly basis, Research & Development rose 22.85% to $38.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was $143.4 million, a 30.05% increase, with the full-year FY2025 number at $143.4 million, up 30.05% from a year prior.
  • Research & Development hit $38.0 million in Q4 2025 for Nova, up from $36.7 million in the prior quarter.
  • In the past five years, Research & Development ranged from a high of $38.0 million in Q4 2025 to a low of $14.5 million in Q1 2021.
  • Median Research & Development over the past 5 years was $23.0 million (2022), compared with a mean of $24.9 million.
  • Biggest five-year swings in Research & Development: dropped 18.76% in 2023 and later soared 45.18% in 2024.
  • Nova's Research & Development stood at $20.1 million in 2021, then surged by 30.12% to $26.2 million in 2022, then dropped by 18.76% to $21.3 million in 2023, then skyrocketed by 45.18% to $30.9 million in 2024, then grew by 22.85% to $38.0 million in 2025.
  • The last three reported values for Research & Development were $38.0 million (Q4 2025), $36.7 million (Q3 2025), and $35.4 million (Q2 2025) per Business Quant data.